fluorescein-5-isothiocyanate has been researched along with amyloid beta-peptides in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hashimoto, T; Iwatsubo, T; Ohtsuki, S; Tamaki, C; Terasaki, T; Yabuki, C; Yamada, K | 1 |
Cribbs, DH; Davies, TA; Eisenhauer, PB; Fine, RE; Hastey, R; Long, HJ; Simons, ER | 1 |
Bilcer, G; Chang, WP; Da, H; Devasamudram, T; Downs, D; Ghosh, AK; Gordon, B; Koelsch, G; Tang, J; Weerasena, V; Wong, S | 1 |
3 other study(ies) available for fluorescein-5-isothiocyanate and amyloid beta-peptides
Article | Year |
---|---|
Major involvement of low-density lipoprotein receptor-related protein 1 in the clearance of plasma free amyloid beta-peptide by the liver.
Topics: Age Factors; Amino Acid Sequence; Amyloid beta-Peptides; Animals; Cells, Cultured; Fluorescein-5-isothiocyanate; Hepatocytes; Injections, Intravenous; Iodine Radioisotopes; LDL-Receptor Related Protein-Associated Protein; Liver; Low Density Lipoprotein Receptor-Related Protein-1; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Molecular Sequence Data; Peptide Fragments; Rats; Rats, Sprague-Dawley | 2006 |
Beta amyloid fragments derived from activated platelets deposit in cerebrovascular endothelium: usage of a novel blood brain barrier endothelial cell model system.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Blood Platelets; Blood-Brain Barrier; Brain; Cells, Cultured; Endothelium, Vascular; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Male; Microscopy, Confocal; Middle Aged; Peptide Fragments; Platelet Activation; Protein Processing, Post-Translational | 2000 |
In vivo inhibition of Abeta production by memapsin 2 (beta-secretase) inhibitors.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Blood-Brain Barrier; Brain; Cell Line; Cell Membrane; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Carriers; Drug Evaluation, Preclinical; Endopeptidases; Enzyme Inhibitors; Fluorescein-5-isothiocyanate; Humans; Injections, Intraperitoneal; Mice; Mice, Transgenic; Oligopeptides; Peptide Fragments; Peptides | 2004 |